• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • R. Garzon, S. Liu, +19 authors G. Marcucci
  • Biology, Medicine
  • Blood
  • 2009 (First Publication: 18 June 2009)
  • Aberrant DNA hypermethylation contributes to myeloid leukemogenesis by silencing structurally normal genes involved in hematopoiesis. MicroRNAs (miRNAs) are noncoding RNAs that regulate geneExpand
  • Paolo Neviani, Ramasamy Santhanam, +14 authors Danilo Perrotti
  • Biology, Medicine
  • Cancer cell
  • 2005 (First Publication: 1 November 2005)
  • The oncogenic BCR/ABL kinase activity induces and maintains chronic myelogenous leukemia (CML). We show here that, in BCR/ABL-transformed cells and CML blast crisis (CML-BC) progenitors, theExpand
  • Joel A. Black, Shujun Liu, Masaki Tanaka, Theodore R. Cummins, Stephen G. Waxman
  • Medicine
  • Pain
  • 2004 (First Publication: 1 April 2004)
  • &NA; Nociceptive neurons within dorsal root ganglia (DRG) express multiple voltage‐gated sodium channels, of which the tetrodotoxin‐resistant (TTX‐R) channel Nav1.8 has been suggested to play a majorExpand
  • Paolo Neviani, Ramasamy Santhanam, +17 authors Danilo Perrotti
  • Medicine
  • The Journal of clinical investigation
  • 2007 (First Publication: 4 September 2007)
  • Blast crisis chronic myelogenous leukemia (CML-BC) and Philadelphia chromosome-positive (Ph1-positive) acute lymphocytic leukemia (ALL) are 2 fatal BCR/ABL-driven leukemias against which Abl kinaseExpand
  • William G. Blum, Rebecca B. Klisovic, +15 authors Guido Marcucci
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 1 September 2007)
  • PURPOSE To determine an optimal biologic dose (OBD) of decitabine as a single agent and then the maximum-tolerated dose (MTD) of valproic acid (VA) combined with decitabine in acute myeloid leukemiaExpand
  • Z. Liu, Z. Xie, +9 authors K. Chan
  • Chemistry, Medicine
  • Bioorganic & medicinal chemistry letters
  • 2009 (First Publication: 1 February 2009)
  • Molecular docking of the interaction of curcumin and DNMT1 suggested that curcumin covalently blocks the catalytic thiolate of C1226 of DNMT1 to exert its inhibitory effect. This was validated byExpand
  • Sebastian Schwind, Kati S. Maharry, +18 authors Clara D. Bloomfield
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 20 December 2010)
  • PURPOSE To evaluate the prognostic significance of expression levels of a single microRNA, miR-181a, in the context of established molecular markers in cytogenetically normal acute myeloid leukemiaExpand